PARP1 and thyroid cancer: Furthermore, transfection of SLC6A9-1 into resistant thyroid cancer cells also enhanced the expression of PARP-1, PAR and γH2AX, indicating more active DNA repair (Figure 5d)(Supplementary Figure S4b).